Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Country Overviews Market Research Reports

Titlepublishedprice

Israel Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... . An uptick in economic growth and an increase to government funding supports our moderate growth outlook for Israel's pharmaceuticals and healthcare sectors over the coming years. Headline Expenditure Projections ? Pharmaceut......"
30-Nov-2016$1295

Italy Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... o access these medicines, will lead to complex pricing and reimbursement discussions, placing downward pressures on drugmaker revenue streams. Despite a long-term decline in the public expenditure of medicines, the implementation of......"
30-Nov-2016$1295

Jordan Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... of the traditional Middle Eastern pharmaceutical markets. The strengthening of pre-existing ties will support local drugmakers' attempts to boost their export potential and further trade with the important developed markets of the U......"
30-Nov-2016$1295

Lebanon Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... an increase in primary healthcare centres opening, providing greater access to the country's most vulnerable people. Over the long term, we expect a growing and ageing population, coupled with relatively high per capita spending, to contr......"
30-Nov-2016$1295

Mauritius Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... l peers including India, Pakistan and the East African Community bodes well for Mauritius' efforts to gradually strengthen its position as a biomedicine manufacturing hub and medical tourism destination. That said, we highlight that......"
30-Nov-2016$1295

Philippines Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... uch as a lack of human resources, poor patient accessibility to clinics and hospitals and limited insurance coverage will all hold back growth in the healthcare sector. Headline Expenditure Projections ? Pharmaceuticals: PHP15......"
30-Nov-2016$1295

Poland Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... thcare system will drive long-term growth. Headline Expenditure Projections ? Pharmaceuticals: PLN33.39bn (USD8.86bn) in 2015 to PLN34.79bn (USD8.56bn) in 2016; +4.2% in local currency terms and -3.4% in US dollar terms. Forec......"
30-Nov-2016$1295

Romania Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... iations on medicine pricing and procurement will limit revenue-earning opportunities. Headline Expenditure Projections ? Pharmaceuticals: RON14.94bn (USD3.73bn) in 2015 to RON15.90bn (USD3.80bn) in 2016; 6.4% in local currency......"
30-Nov-2016$1295

Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... ion is a major draw for multinationals pharmaceutical companies, given that the Saudi Arabian drug market remains import-reliant. Furthermore, the kingdom's increasing focus on healthcare and social provision is going to be a long-t......"
30-Nov-2016$1295

United States Pharmaceuticals and Healthcare Report Q1 2017

By Business Monitor International
"...... armaceutical spending, in contrast, lower tax rates and a subsequent boost in corporate activity pose upside risk. Nevertheless, drug pricing remains the key issue worrying drugmakers and this concern has been present well before both......"
30-Nov-2016$1295

Avail upto 50% Discount on below Publisher Reports.